|
KMID : 1030220230240030135
|
|
Journal of Korean Diabetes
2023 Volume.24 No. 3 p.135 ~ p.140
|
|
|
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
|
|
Lee Min-Hee
|
|
|
Abstract
|
|
|
|
To prevent cardiovascular disease (CVD), which is one of the ultimate goals in the management of patients with diabetes, it is important to control not only hyperglycemia, but also modifiable CVD risk factors such as hypertension and dyslipidemia. In addition, antiplatelet agents should be used under appropriate conditions. It is necessary to evaluate whether the patient has CVD, the degree of other complications, the presence of comorbidities or other CVD risk factors, and the duration of diabetes. In this article, I will review the revised and key points of the 8th edition of the Korean Diabetes Association clinical practice guidelines for management of hypertension and dyslipidemia and the use of antiplatelet agents in patients with diabetes.
|
|
|
KEYWORD
|
|
|
Cardiovascular diseases, Diabetes mellitus, type 2, Dyslipidemias, Hypertension, Platelet aggregation inhibitors, Practice guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|